Cargando…
Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance
Glioblastoma (GBM) is the most malignant and lethal brain tumor. Current standard treatment consists of surgery followed by radiotherapy/chemotherapy; however, this is only a palliative approach with a mean post-operative survival of scarcely ~12–15 months. Thus, the identification of novel therapeu...
Autores principales: | Fuentes-Fayos, Antonio C., G-García, Miguel E., Pérez-Gómez, Jesús M., Peel, Annabel, Blanco-Acevedo, Cristóbal, Solivera, Juan, Ibáñez-Costa, Alejandro, Gahete, Manuel D., Castaño, Justo P., Luque, Raúl M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835306/ https://www.ncbi.nlm.nih.gov/pubmed/35163067 http://dx.doi.org/10.3390/ijms23031143 |
Ejemplares similares
-
Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors
por: Sampedro-Núñez, Miguel, et al.
Publicado: (2015) -
The Truncated Isoform of Somatostatin Receptor5 (sst5TMD4) Is Associated with Poorly Differentiated Thyroid Cancer
por: Puig-Domingo, Manel, et al.
Publicado: (2014) -
The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients
por: Gahete, Manuel D., et al.
Publicado: (2016) -
Epigenetic and post‐transcriptional regulation of somatostatin receptor subtype 5 (SST(5)) in pituitary and pancreatic neuroendocrine tumors
por: Pedraza‐Arevalo, Sergio, et al.
Publicado: (2021) -
Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3
por: Fuentes-Fayos, Antonio C, et al.
Publicado: (2020)